Showing results (261-270 of 328) with videos related to
Sort By:
Pageof 33
Plos One|May 3, 2011
Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infantsSarah Burl, John Townend, Jainaba Njie-Jobe, et al.Journal of Medicinal Chemistry|December 23, 1994
Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.Frontiers in Immunology|June 26, 2020
Limited Impact of Human Cytomegalovirus Infection in African Infants on Vaccine-Specific Responses Following Diphtheria-Tetanus-Pertussis and Measles VaccinationMomodou Cox, Jane U Adetifa, Fatou Noho-Konteh, et al.European Journal of Immunology|December 30, 2009
The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birthKatie L Flanagan, Alice Halliday, Sarah Burl, et al.Tissue Engineering. Part A|December 22, 2017
A Mineralized Collagen-Polycaprolactone Composite Promotes Healing of a Porcine Mandibular DefectDaniel W Weisgerber, Derek J Milner, Heather Lopez-Lake, et al.Vaccine|February 2, 2022
Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential mannerLaure F Pittet, Lianne Cox, Bridget Freyne, et al.Journal of Molecular Medicine (Berlin, Germany)|November 13, 2014
BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancerL Flanagan, A U Lindner, C de Chaumont, et al.Cell Death & Disease|February 5, 2016
Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approachL Flanagan, M Meyer, J Fay, et al.Plos One|November 9, 2013
A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infantsMuhammed O Afolabi, Jorjoh Ndure, Abdoulie Drammeh, et al.Pageof 33